The discovery and development of topical medicines for wound healing

References

• Funk DJ, Parrillo JE, Kumar A. Sepsis and septic shock: a history. Crit Care Clin. 2009;25:83–101.
   PubMed Web of Science ®Google Scholar
• Shah JB. The history of wound care. J Am Coll Certif Wound Spec. 2011;3:65–66.
   PubMedGoogle Scholar
• Moura Neto A, Zantut-Wittmann DE, Fernandes TD, et al. Risk factors for ulceration and amputation in diabetic foot: study in a cohort of 496 patients. Endocrine. 2013;44:119–124.
   PubMed Web of Science ®Google Scholar
• Chan B, Cadarette S, Wodchis W, et al. Cost-of-illness studies in chronic ulcers: a systematic review. J Wound Care. 2017;26:S4–S14.
   PubMed Web of Science ®Google Scholar
• Heyer K, Herberger K, Protz K, et al. Epidemiology of chronic wounds in Germany: analysis of statutory health insurance data: epidemiology of chronic wounds in Germany. Wound Repair Regen. 2016;24:434–442.
   PubMed Web of Science ®Google Scholar
• Guest JF, Ayoub N, McIlwraith T, et al. Health economic burden that wounds impose on the National Health Service in the UK. BMJ Open. 2015;5:e009283.
   PubMed Web of Science ®Google Scholar
• Gottrup F. A specialized wound-healing center concept: importance of a multidisciplinary department structure and surgical treatment facilities in the treatment of chronic wounds. Am J Surg. 2004;187:S38–S43.
   PubMed Web of Science ®Google Scholar
• Sen CK, Gordillo GM, Roy S, et al. Human skin wounds: A major and snowballing threat to public health and the economy. Wound Repair Regen. 2009;17:763–771.
   PubMed Web of Science ®Google Scholar
• Gurtner GC, Werner S, Barrandon Y, et al. Wound repair and regeneration. Nature. 2008;453:314–321.
   PubMed Web of Science ®Google Scholar
• Werner S, Grose R. Regulation of wound healing by growth factors and cytokines. Physiol Rev. 2003;83:835–870.
   PubMed Web of Science ®Google Scholar
• Herndon DN, Tompkins RG. Support of the metabolic response to burn injury. Lancet. 2004;363:1895–1902.
   PubMed Web of Science ®Google Scholar
• Phillipson M, Kubes P. The neutrophil in vascular inflammation. Nat Med. 2011;17:1381–1390.
   PubMed Web of Science ®Google Scholar
• Bianchi ME. DAMPs, PAMPs and alarmins: all we need to know about danger. J Leukoc Biol. 2007;81:1–5.
   PubMed Web of Science ®Google Scholar
• Sullivan TP, Eaglstein WH, Davis SC, et al. The pig as a model for human wound healing. Wound Repair Regen. 2001;9:66–76.
   PubMed Web of Science ®Google Scholar
• Yager DR, Nwomeh BC. The proteolytic environment of chronic wounds. Wound Repair Regen. 1999;7:433–441.
   PubMed Web of Science ®Google Scholar
• Rahim K, Saleha S, Zhu X, et al. Bacterial contribution in chronicity of wounds. Microb Ecol. 2017;73:710–721.
   PubMed Web of Science ®Google Scholar
• Demidova-Rice TN, Hamblin MR, Herman IM. Acute and impaired wound healing: pathophysiology and current methods for drug delivery, part 1. Adv Skin Wound Care. 2012;25:304–314.
   PubMed Web of Science ®Google Scholar
• Malone M, Bjarnsholt T, McBain AJ, et al. The prevalence of biofilms in chronic wounds: a systematic review and meta-analysis of published data. J Wound Care. 2017;26:20–25.
   PubMed Web of Science ®Google Scholar
• Percival SL, Hill KE, Williams DW, et al. A review of the scientific evidence for biofilms in wounds: biofilms in wounds. Wound Repair Regen. 2012;20:647–657.
   PubMed Web of Science ®Google Scholar
• Schultz G, Bjarnsholt T, James GA, et al. Consensus guidelines for the identification and treatment of biofilms in chronic nonhealing wounds: guidelines for chronic wound biofilms. Wound Repair Regen. 2017;25:744–757.
   PubMed Web of Science ®Google Scholar
• Devalaraja RM, Nanney LB, Qian Q, et al. Delayed wound healing in CXCR2 knockout mice. J Invest Dermatol. 2000;115:234–244.
   PubMed Web of Science ®Google Scholar
• Dovi JV, He L-K, DiPietro LA. Accelerated wound closure in neutrophil-depleted mice. J Leukoc Biol. 2003;73:448–455.
   PubMed Web of Science ®Google Scholar
• Nishio N, Okawa Y, Sakurai H, et al. Neutrophil depletion delays wound repair in aged mice. Age (Omaha). 2008;30:11–19.
   PubMedGoogle Scholar
• Christoffersson G, Vagesjo E, Vandooren J, et al. VEGF-A recruits a proangiogenic MMP-9-delivering neutrophil subset that induces angiogenesis in transplanted hypoxic tissue. Blood. 2012;120:4653–4662.
   PubMed Web of Science ®Google Scholar
• Massena S, Christoffersson G, Vagesjo E, et al. Identification and characterization of VEGF-A-responsive neutrophils expressing CD49d, VEGFR1, and CXCR4 in mice and humans. Blood. 2015;126:2016–2026.
   PubMed Web of Science ®Google Scholar
• Lucas T, Waisman A, Ranjan R, et al. Differential roles of macrophages in diverse phases of skin repair. J Immunol. 2010;184:3964–3977.
   PubMed Web of Science ®Google Scholar
• Wynn TA, Vannella KM. Macrophages in tissue repair, regeneration, and fibrosis. Immunity. 2016;44:450–462.
   PubMed Web of Science ®Google Scholar
• Boniakowski AE, Kimball AS, Jacobs BN, et al. Macrophage-mediated inflammation in normal and diabetic wound healing. J Immunol. 2017;199:17–24.
   PubMed Web of Science ®Google Scholar
• Krzyszczyk P, Schloss R, Palmer A, et al. The role of macrophages in acute and chronic wound healing and interventions to promote pro-wound healing phenotypes. Front Physiol. [Internet]. 2018 [cited 2018 Nov 2];9. DOI:10.3389/fphys.2018.00419/full
   PubMed Web of Science ®Google Scholar
• Snyder RJ, Lantis J, Kirsner RS, et al. Macrophages: A review of their role in wound healing and their therapeutic use: review of macrophages in wound healing. Wound Repair Regen. 2016;24:613–629.
   PubMed Web of Science ®Google Scholar
• Leung A, Crombleholme TM, Keswani SG. Fetal wound healing: implications for minimal scar formation. Curr Opin Pediatr. 2012;24:371–378.
   PubMed Web of Science ®Google Scholar
• Gawronska-Kozak B, Bogacki M, Rim J-S, et al. Scarless skin repair in immunodeficient mice: scarless skin repair in immundeficient mice. Wound Repair Regen. 2006;14:265–276.
   PubMed Web of Science ®Google Scholar
• Zlotnik A, Yoshie O. Chemokines: a new classification system and their role in immunity. Immunity. 2000;12:121–127.
   PubMed Web of Science ®Google Scholar
• Murdoch C, Finn A. Chemokine receptors and their role in inflammation and infectious diseases. Blood. 2000;95:3032–3043.
   PubMed Web of Science ®Google Scholar
• Griffith JW, Sokol CL, Luster AD. Chemokines and chemokine receptors: positioning cells for host defense and immunity. Annu Rev Immunol. 2014;32:659–702.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Foudi A, Geay J-F, et al. Intracellular localization and constitutive endocytosis of CXCR4 in human CD34 + hematopoietic progenitor cells. Stem Cells. 2004;22:1015–1029.
   PubMed Web of Science ®Google Scholar
• Proost P, Struyf S, Schols D, et al. Processing by CD26/dipeptidyl-peptidase IV reduces the chemotactic and anti-HIV-1 activity of stromal-cell-derived factor-1alpha. FEBS Lett. 1998;432:73–76.
   PubMed Web of Science ®Google Scholar
• Lambeir A-M, Proost P, Durinx C, et al. Kinetic investigation of chemokine truncation by CD26/Dipeptidyl Peptidase IV reveals a striking selectivity within the chemokine family. J Biol Chem. 2001;276:29839–29845.
   PubMed Web of Science ®Google Scholar
• Mortier A, Gouwy M, Van Damme J, et al. CD26/dipeptidylpeptidase IV-chemokine interactions: double-edged regulation of inflammation and tumor biology. J Leukoc Biol. 2016;99:955–969.
   PubMed Web of Science ®Google Scholar
• Ridiandries A, Tan J, Bursill C. The role of chemokines in wound healing. Int J Mol Sci. 2018;19:3217.
   PubMed Web of Science ®Google Scholar
• Barrientos S, Stojadinovic O, Golinko MS, et al. PERSPECTIVE ARTICLE: growth factors and cytokines in wound healing: growth factors and cytokines in wound healing. Wound Repair Regen. 2008;16:585–601.
   PubMed Web of Science ®Google Scholar
• Park J, Hwang S, Yoon I-S. Advanced growth factor delivery systems in wound management and skin regeneration. Molecules. 2017;22:1259.
   PubMed Web of Science ®Google Scholar
• Beer HD, Longaker MT, Werner S. Reduced expression of PDGF and PDGF receptors during impaired wound healing. J Invest Dermatol. 1997;109:132–138.
   PubMed Web of Science ®Google Scholar
• Beer HD, Fässler R, Werner S. Glucocorticoid-regulated gene expression during cutaneous wound repair. Vitam Horm. 2000;59:217–239.
   PubMedGoogle Scholar
• Blakytny R, Jude E. The molecular biology of chronic wounds and delayed healing in diabetes. Diabet Med. 2006;23:594–608.
   PubMed Web of Science ®Google Scholar
• Gay D, Kwon O, Zhang Z, et al. Fgf9 from dermal γδ T cells induces hair follicle neogenesis after wounding. Nat Med. 2013;19:916–923.
   PubMed Web of Science ®Google Scholar
• Jameson J. A role for skin gamma delta T cells in wound repair. Science. 2002;296:747–749.
   PubMed Web of Science ®Google Scholar
• Sharp LL, Jameson JM, Cauvi G, et al. Dendritic epidermal T cells regulate skin homeostasis through local production of insulin-like growth factor 1. Nat Immunol. 2005;6:73–79.
   PubMed Web of Science ®Google Scholar
• Brownell I, Guevara E, Bai CB, et al. Nerve-derived sonic hedgehog defines a niche for hair follicle stem cells capable of becoming epidermal stem cells. Cell Stem Cell. 2011;8:552–565.
   PubMed Web of Science ®Google Scholar
• Ito M, Liu Y, Yang Z, et al. Stem cells in the hair follicle bulge contribute to wound repair but not to homeostasis of the epidermis. Nat Med. 2005;11:1351–1354.
   PubMed Web of Science ®Google Scholar
• Levy V, Lindon C, Zheng Y, et al. Epidermal stem cells arise from the hair follicle after wounding. FASEB J. 2007;21:1358–1366.
   PubMed Web of Science ®Google Scholar
• Mascré G, Dekoninck S, Drogat B, et al. Distinct contribution of stem and progenitor cells to epidermal maintenance. Nature. 2012;489:257–262.
   PubMed Web of Science ®Google Scholar
• Page ME, Lombard P, Ng F, et al. The epidermis comprises autonomous compartments maintained by distinct stem cell populations. Cell Stem Cell. 2013;13:471–482.
   PubMed Web of Science ®Google Scholar
• Tumbar T. Defining the epithelial stem cell niche in skin. Science. 2004;303:359–363.
   PubMed Web of Science ®Google Scholar
• Langton AK, Herrick SE, Headon DJ. An extended epidermal response heals cutaneous wounds in the absence of a hair follicle stem cell contribution. J Invest Dermatol. 2008;128:1311–1318.
   PubMed Web of Science ®Google Scholar
• Singer AJ, Dagum AB. Current management of acute cutaneous wounds. N Engl J Med. 2008;359:1037–1046.
   PubMed Web of Science ®Google Scholar
• International best practice guidelines: wound management in diabetic woot ulcers [Internet]. Wound international; 2013. [cited 2018 Nov 16].  Available from: www.woundinternational.com
   Google Scholar
• U.S. Food & Drug Administration. PMA approvals [Internet]; 2018 [cited 2018 Nov 19]. Available from: https://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/DeviceApprovalsandClearances/PMAApprovals/default.htm
   Google Scholar
• Papanas N, Maltezos E. Becaplermin gel in the treatment of diabetic neuropathic foot ulcers. Clin Interv Aging. 2008;3:233–240.
   PubMed Web of Science ®Google Scholar
• Dhivya S, Padma VV, Santhini E. Wound dressings – a review. Biomedicine (Taipei). [Internet]. 2015 [cited 2018 Nov 2];5. Available from: http://www.globalsciencejournals.com/article/10.7603/s40681-015-0022-9
   PubMedGoogle Scholar
• Simader E, Traxler D, Kasiri MM, et al. Safety and tolerability of topically administered autologous, apoptotic PBMC secretome (APOSEC) in dermal wounds: a randomized Phase 1 trial (MARSYAS I). Sci Rep. 2017;7:6216.
   PubMed Web of Science ®Google Scholar
• Gardien KLM, Marck RE, Bloemen MCT, et al. Outcome of burns treated with autologous cultured proliferating epidermal cells: a prospective randomized multicenter intrapatient comparative trial. Cell Transplant. 2016;25:437–448.
   PubMed Web of Science ®Google Scholar
• Valentini SR, Nogueira AC, Fenelon VC, et al. Insulin complexation with hydroxypropyl-beta-cyclodextrin: spectroscopic evaluation of molecular inclusion and use of the complex in gel for healing of pressure ulcers. Int J Pharm. 2015;490:229–239.
   PubMedGoogle Scholar
• Lantis IJC, Gordon I. Clostridial collagenase for the management of diabetic foot ulcers: results of four randomized controlled trials. Wounds Compend Clin Res Pract. 2017;29:297–305.
   Web of Science ®Google Scholar
• Tonaco LAB, Gomes FL, Velasquez-Melendez G, et al. The proteolytic fraction from latex of vasconcellea cundinamarcensis (P1G10) enhances wound healing of diabetic foot ulcers: a double-blind randomized pilot study. Adv Ther. 2018;35:494–502.
   PubMed Web of Science ®Google Scholar
• Barrientos S, Brem H, Stojadinovic O, et al. Clinical application of growth factors and cytokines in wound healing: wound management: growth factors & cytokines. Wound Repair Regen. 2014;22:569–578.
   PubMed Web of Science ®Google Scholar
• Lobmann R, Ambrosch A, Schultz G, et al. Expression of matrix-metalloproteinases and their inhibitors in the wounds of diabetic and non-diabetic patients. Diabetologia. 2002;45:1011–1016.
   PubMed Web of Science ®Google Scholar
• Da Costa RM, Jesus FMR, Aniceto C, et al. Randomized, double-blind, placebo-controlled, dose- ranging study of granulocyte-macrophage colony stimulating factor in patients with chronic venous leg ulcers. Wound Repair Regen. 1999;7:17–25.
   PubMed Web of Science ®Google Scholar
• Park KH, Han SH, Hong JP, et al. Topical epidermal growth factor spray for the treatment of chronic diabetic foot ulcers: A phase III multicenter, double-blind, randomized, placebo-controlled trial. Diabetes Res Clin Pract. 2018;142:335–344.
   PubMed Web of Science ®Google Scholar
• Yuan L, Minghua C, Feifei D, et al. Study of the use of recombinant human granulocyte-macrophage colony-stimulating factor hydrogel externally to treat residual wounds of extensive deep partial-thickness burn. Burns. 2015;41:1086–1091.
   PubMed Web of Science ®Google Scholar
• Mulder G, Tallis AJ, Marshall VT, et al. Treatment of nonhealing diabetic foot ulcers with a platelet-derived growth factor gene-activated matrix (GAM501): results of a Phase 1/2 trial. Wound Repair Regen. 2009;17:772–779.
   PubMed Web of Science ®Google Scholar
• Chicharro-Alcántara D, Rubio-Zaragoza M, Damiá-Giménez E, et al. Platelet rich plasma: new insights for cutaneous wound healing management. J Funct Biomater. 2018;9:10.
   Web of Science ®Google Scholar
• Martinez-Zapata MJ, Martí-Carvajal AJ, Solà I, et al. Autologous platelet-rich plasma for treating chronic wounds. Cochrane Wounds Group, editor. Cochrane Database Syst Rev. [Internet]. 2016 [cited 2018 Nov 2]. DOI:10.1002/14651858.CD006899.pub3
   Web of Science ®Google Scholar
• U.S. Food & Drug Administration. 2017 biological device application approvals [Internet]; 2018 [cited 2018 Nov 19]. Available from: https://www.fda.gov/BiologicsBloodVaccines/DevelopmentApprovalProcess/BiologicalApprovalsbyYear/ucm547560.htm
   Google Scholar
• Wood S, Jayaraman V, Huelsmann EJ, et al. Pro-inflammatory chemokine CCL2 (MCP-1) promotes healing in diabetic wounds by restoring the macrophage response. PloS One. 2014;9:e91574.
   PubMed Web of Science ®Google Scholar
• Nakamura Y, Ishikawa H, Kawai K, et al. Enhanced wound healing by topical administration of mesenchymal stem cells transfected with stromal cell-derived factor-1. Biomaterials. 2013;34:9393–9400.
   PubMed Web of Science ®Google Scholar
• Miller TJ, Henson K, Aras R, et al. 500. stromal cell-derived factor-1 non-viral DNA therapy accelerates wound healing and decreases scar formation in porcine surgical incisions. Mol Ther. 2013;21:S193.
   Web of Science ®Google Scholar
• Segers VFM, Revin V, Wu W, et al. Protease-resistant stromal cell–derived factor-1 for the treatment of experimental peripheral artery diseaseclinical perspective. Circulation. 2011;123:1306–1315.
   PubMedGoogle Scholar
• Davis FM, Gallagher K. Time heals all wounds … but wounds heal faster with lactobacillus. Cell Host Microbe. 2018;23:432–434.
   PubMed Web of Science ®Google Scholar
• Vågesjö E, Öhnstedt E, Mortier A, et al. Accelerated wound healing in mice by on-site production and delivery of CXCL12 by transformed lactic acid bacteria. Proc Natl Acad Sci. 2018;115:1895–1900.
   PubMed Web of Science ®Google Scholar
• Ridiandries A, Bursill C, Tan J. Broad-spectrum inhibition of the CC-chemokine class improves wound healing and wound angiogenesis. Int J Mol Sci. 2017;18(1): 115.
   Web of Science ®Google Scholar
• Kanji S, Das H. Advances of stem cell therapeutics in cutaneous wound healing and regeneration. Mediators Inflamm. 2017;2017:1–14.
   Google Scholar
• Marfia G, Navone SE, Di Vito C, et al. Mesenchymal stem cells: potential for therapy and treatment of chronic non-healing skin wounds. Organogenesis. 2015;11:183–206.
   PubMed Web of Science ®Google Scholar
• Biomendics. TolaSure [Internet]; [ cited 2018 Nov 19]. Available from: http://www.biomendics.com/about-biomendics/
   Google Scholar
• Gu X, Shen S, Huang C, et al. Effect of activated autologous monocytes/macrophages on wound healing in a rodent model of experimental diabetes. Diabetes Res Clin Pract. 2013;102:53–59.
   PubMed Web of Science ®Google Scholar
• Jetten N, Roumans N, Gijbels MJ, et al. Wound administration of M2-polarized macrophages does not improve murine cutaneous healing responses. Brandner JM, editor. PLoS ONE. 2014;9:e102994.
   PubMed Web of Science ®Google Scholar
• Zuloff-Shani A, Adunsky A, Even-Zahav A, et al. Hard to heal pressure ulcers (stage III–IV): efficacy of injected activated macrophage suspension (AMS) as compared with standard of care (SOC) treatment controlled trial. Arch Gerontol Geriatr. 2010;51:268–272.
   PubMed Web of Science ®Google Scholar
• Mulholland EJ, Dunne N, McCarthy HO. MicroRNA as therapeutic targets for chronic wound healing. Mol Ther Nucleic Acids. 2017;8:46–55.
   PubMedGoogle Scholar
• Lucas T, Schäfer F, Müller P, et al. Light-inducible antimiR-92a as a therapeutic strategy to promote skin repair in healing-impaired diabetic mice. Nat Commun. 2017;8:15162.
   PubMed Web of Science ®Google Scholar
• Gallant-Behm CL, Piper J, Dickinson BA, et al. A synthetic microRNA-92a inhibitor (MRG-110) accelerates angiogenesis and wound healing in diabetic and nondiabetic wounds: MRG-110 accelerates wound healing. Wound Repair Regen. [Internet]. 2018 [cited 2018 Nov 2]. DOI:10.1111/wrr.12660.
   PubMed Web of Science ®Google Scholar
• Bowdish D, Davidson D, Hancock R. A re-evaluation of the role of host defence peptides in mammalian immunity. Curr Protein Pept Sci. 2005;6:35–51.
   PubMed Web of Science ®Google Scholar
• Scott MG, Davidson DJ, Gold MR, et al. The human antimicrobial peptide LL-37 is a multifunctional modulator of innate immune responses. J Immunol (Baltimore, MD). 1950;2002(169):3883–3891.
   Google Scholar
• Tomasinsig L, Pizzirani C, Skerlavaj B, et al. The human cathelicidin LL-37 modulates the activities of the P2X 7 receptor in a structure-dependent manner. J Biol Chem. 2008;283:30471–30481.
   PubMed Web of Science ®Google Scholar
• Andersson DI, Hughes D, Kubicek-Sutherland JZ. Mechanisms and consequences of bacterial resistance to antimicrobial peptides. Drug Resist Updat. 2016;26:43–57.
   PubMed Web of Science ®Google Scholar
• Liu -Y-Y, Wang Y, Walsh TR, et al. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect Dis. 2016;16:161–168.
   PubMed Web of Science ®Google Scholar
• Bradshaw JP. Cationic antimicrobial peptides: issues for potential clinical use. BioDrugs. 2003;17:233–240.
   PubMed Web of Science ®Google Scholar
• Vaara M. New approaches in peptide antibiotics. Curr Opin Pharmacol. 2009;9:571–576.
   PubMed Web of Science ®Google Scholar
• Gomes A, Teixeira C, Ferraz R, et al. Wound-healing peptides for treatment of chronic diabetic foot ulcers and other infected skin injuries. Molecules. 2017;22:1743.
   PubMed Web of Science ®Google Scholar
• Agerberth B, Charo J, Werr J, et al. The human antimicrobial and chemotactic peptides LL-37 and alpha-defensins are expressed by specific lymphocyte and monocyte populations. Blood. 2000;96:3086–3093.
   PubMed Web of Science ®Google Scholar
• Vermeulen H, van Hattem JM, Storm-Versloot MN, et al. Topical silver for treating infected wounds. Cochrane Wounds Group, editor. Cochrane Database Syst Rev. [Internet]. 2007 [cited 2018 Nov 16]. DOI:10.1002/14651858.CD005486.pub2
   Web of Science ®Google Scholar
• Nherera LM, Trueman P, Roberts CD, et al. A systematic review and meta-analysis of clinical outcomes associated with nanocrystalline silver use compared to alternative silver delivery systems in the management of superficial and deep partial thickness burns. Burns. 2017;43:939–948.
   PubMed Web of Science ®Google Scholar
• Ebeling S, Naumann K, Pollok S, et al. From a traditional medicinal plant to a rational drug: understanding the clinically proven wound healing efficacy of birch bark extract. Simon M, editor. PLoS ONE. 2014;9:e86147.
   PubMed Web of Science ®Google Scholar
• Barret JP, Podmelle F, Lipový B, et al. Accelerated re-epithelialization of partial-thickness skin wounds by a topical betulin gel: results of a randomized phase III clinical trials program. Burns. 2017;43:1284–1294.
   PubMed Web of Science ®Google Scholar
• Gasca-Lozano LE, Lucano-Landeros S, Ruiz-Mercado H, et al. Pirfenidone accelerates wound healing in chronic diabetic foot ulcers: a randomized, double-blind controlled trial. J Diabetes Res. 2017;2017:1–12.
   Google Scholar
• Janka-Zires M, Almeda-Valdes P, Uribe-Wiechers AC, et al. Topical administration of pirfenidone increases healing of chronic diabetic foot ulcers: a randomized crossover study. J Diabetes Res. 2016;2016:1–7.
   Google Scholar
• Totsuka Sutto SE, Rodríguez Roldan YI, Cardona Muñoz EG, et al. Efficacy and safety of the combination of isosorbide dinitrate spray and chitosan gel for the treatment of diabetic foot ulcers: A double-blind, randomized, clinical trial. Diab Vasc Dis Res. 2018;15:348–351.
   PubMed Web of Science ®Google Scholar
• Nicholas MN, Yeung J. Current status and future of skin substitutes for chronic wound healing. J Cutan Med Surg. 2017;21:23–30.
   PubMed Web of Science ®Google Scholar
• Nathoo R, Howe N, Cohen G. Skin substitutes: an overview of the key players in wound management. J Clin Aesthetic Dermatol. 2014;7:44–48.
   PubMedGoogle Scholar
• Lavery LA, Fulmer J, Shebetka KA, et al. The efficacy and safety of Grafix ® for the treatment of chronic diabetic foot ulcers: results of a multi-centre, controlled, randomised, blinded, clinical trial: efficacy and safety of Grafix ®. Int Wound J. 2014;11:554–560.
   PubMed Web of Science ®Google Scholar
• Apelqvist J, Willy C, Fagerdahl A-M, et al. Negative pressure wound therapy - overview, challanges and perspetives. J Wound Care. 2017;26:1–113.
   PubMed Web of Science ®Google Scholar
• Liu Z, Dumville JC, Hinchliffe RJ, et al. Negative pressure wound therapy for treating foot wounds in people with diabetes mellitus. Cochrane Wounds Group, editor. Cochrane Database Syst Rev. [Internet]. 2018 [cited 2018 Nov 15]. DOI:10.1002/14651858.CD010318.pub3
   Web of Science ®Google Scholar
• Dumville JC, Land L, Evans D, et al. Negative pressure wound therapy for treating leg ulcers. Cochrane Wounds Group, editor. Cochrane Database Syst Rev. [Internet]. 2015 [cited 2018 Nov 15]. DOI:10.1002/14651858.CD011354.pub2
   Web of Science ®Google Scholar
• Dumville JC, Munson C, Christie J. Negative pressure wound therapy for partial-thickness burns. Cochrane Wounds Group, editor. Cochrane Database Syst Rev. [Internet]. 2014 [cited 2018 Nov 15]. DOI:10.1002/14651858.CD006215.pub4
   Web of Science ®Google Scholar
• Dumville JC, Webster J, Evans D, et al. Negative pressure wound therapy for treating pressure ulcers. Cochrane Wounds Group, editor. Cochrane Database Syst Rev. [Internet]. 2015 [cited 2018 Nov 15]. DOI:10.1002/14651858.CD011334.pub2
   Web of Science ®Google Scholar
• Iheozor-Ejiofor Z, Newton K, Dumville JC, et al. Negative pressure wound therapy for open traumatic wounds. Cochrane Wounds Group, editor. Cochrane Database Syst Rev. [Internet]. 2018 [cited 2018 Nov 15]. DOI:10.1002/14651858.CD012522.pub2
   Web of Science ®Google Scholar
• Kranke P, Bennett MH, Martyn-St James M, et al. Hyperbaric oxygen therapy for chronic wounds. Cochrane Wounds Group, editor. Cochrane Database Syst Rev. [Internet]. 2015 [cited 2018 Nov 16]. DOI:10.1002/14651858.CD004123.pub4
   Web of Science ®Google Scholar
• Demidova-Rice TN, Hamblin MR, Herman IM Acute and Impaired Wound Healing: Pathophysiology and Current Methods for Drug Delivery, Part 2: Role of Growth Factors in Normal and Pathological Wound Healing: Therapeutic Potential and Methods of Delivery.
   Google Scholar
• Zhu Y, Hoshi R, Chen S, et al. Sustained release of stromal cell derived factor-1 from an antioxidant thermoresponsive hydrogel enhances dermal wound healing in diabetes. J Control Release. 2016;238:114–122.
   PubMed Web of Science ®Google Scholar